Recent Advances and Future Directions in Downstream Processing of Therapeutic Antibodies

Despite the advent of many new therapies, therapeutic monoclonal antibodies remain a prominent biologics product, with a market value of billions of dollars annually. A variety of downstream processing technological advances have led to a paradigm shift in how therapeutic antibodies are developed an...

Descripción completa

Detalles Bibliográficos
Autor principal: Matte, Allan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369434/
https://www.ncbi.nlm.nih.gov/pubmed/35955796
http://dx.doi.org/10.3390/ijms23158663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369434/
https://www.ncbi.nlm.nih.gov/pubmed/35955796
http://dx.doi.org/10.3390/ijms23158663

Ejemplares similares